Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
21.9M
-
Shares change
-
+8.5M
-
Total reported value, excl. options
-
$289M
-
Value change
-
+$115M
-
Put/Call ratio
-
0.66
-
Number of buys
-
45
-
Number of sells
-
-27
-
Price
-
$13.20
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q3 2020
90 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q3 2020.
Altimmune, Inc. - Common Stock (ALT) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.9M shares
of 80.7M outstanding shares and own 27.13% of the company stock.
Largest 10 shareholders include VR Adviser, LLC (4.5M shares), BAKER BROS. ADVISORS LP (2.21M shares), Avoro Capital Advisors LLC (2M shares), D. E. Shaw & Co., Inc. (1.66M shares), ARMISTICE CAPITAL, LLC (1.44M shares), RTW INVESTMENTS, LP (1.33M shares), VANGUARD GROUP INC (1.2M shares), RENAISSANCE TECHNOLOGIES LLC (1.02M shares), Capital World Investors (861K shares), and ACUTA CAPITAL PARTNERS, LLC (688K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.